Review



alpha mouse liver 12 aml12 cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    ATCC alpha mouse liver 12 aml12 cell line
    Alpha Mouse Liver 12 Aml12 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1551 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpha mouse liver 12 aml12 cell line/product/ATCC
    Average 98 stars, based on 1551 article reviews
    alpha mouse liver 12 aml12 cell line - by Bioz Stars, 2026-05
    98/100 stars

    Images



    Similar Products

    98
    ATCC alpha mouse liver 12 aml12 cell line
    Alpha Mouse Liver 12 Aml12 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpha mouse liver 12 aml12 cell line/product/ATCC
    Average 98 stars, based on 1 article reviews
    alpha mouse liver 12 aml12 cell line - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    86
    Procell Inc aml12 mouse hepatocyte cell line
    Aml12 Mouse Hepatocyte Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aml12 mouse hepatocyte cell line/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    aml12 mouse hepatocyte cell line - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    98
    ATCC mouse normal hepatocyte cell line aml12
    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, <t>AML12</t> cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.
    Mouse Normal Hepatocyte Cell Line Aml12, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse normal hepatocyte cell line aml12/product/ATCC
    Average 98 stars, based on 1 article reviews
    mouse normal hepatocyte cell line aml12 - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    98
    ATCC mouse aml12 cell line
    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, <t>AML12</t> cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.
    Mouse Aml12 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse aml12 cell line/product/ATCC
    Average 98 stars, based on 1 article reviews
    mouse aml12 cell line - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    98
    ATCC mouse normal hepatocytes aml12 cell line
    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, <t>AML12</t> cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.
    Mouse Normal Hepatocytes Aml12 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse normal hepatocytes aml12 cell line/product/ATCC
    Average 98 stars, based on 1 article reviews
    mouse normal hepatocytes aml12 cell line - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    98
    ATCC mouse normal liver cell line aml12
    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, <t>AML12</t> cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.
    Mouse Normal Liver Cell Line Aml12, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse normal liver cell line aml12/product/ATCC
    Average 98 stars, based on 1 article reviews
    mouse normal liver cell line aml12 - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    98
    ATCC mouse hepatocyte cell line aml12
    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, <t>AML12</t> cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.
    Mouse Hepatocyte Cell Line Aml12, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse hepatocyte cell line aml12/product/ATCC
    Average 98 stars, based on 1 article reviews
    mouse hepatocyte cell line aml12 - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    98
    ATCC mouse liver cell line aml 12
    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, <t>AML12</t> cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.
    Mouse Liver Cell Line Aml 12, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse liver cell line aml 12/product/ATCC
    Average 98 stars, based on 1 article reviews
    mouse liver cell line aml 12 - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    98
    ATCC alpha mouse liver 12 aml12 mouse hepatocyte cell line
    Lactate-induced lipid accumulation in hepatocytes in vitro . Alpha mouse <t>liver</t> <t>12</t> <t>(AML12)</t> cells were treated with different doses of sodium L-lactate for 4 days. (A) Cell viability was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (B) Intracellular lipid is stained with Oil Red O. The upper images representative gross morphology of Oil Red O staining of AML12 cells. The below representative pictures of cells were taken by a microscope at 200× original magnification. Scale bar: 100 μm. (C) Quantification of intracellular triglyceride (TG) content. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001.
    Alpha Mouse Liver 12 Aml12 Mouse Hepatocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpha mouse liver 12 aml12 mouse hepatocyte cell line/product/ATCC
    Average 98 stars, based on 1 article reviews
    alpha mouse liver 12 aml12 mouse hepatocyte cell line - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, AML12 cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.

    Journal: Science Advances

    Article Title: SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth

    doi: 10.1126/sciadv.aec4368

    Figure Lengend Snippet: ( A ) Liver tumor tissues were collected from the HTVi model and clinical patients and subjected to untargeted metabolomic profiling for pathway enrichment. ( B ) Summarized SLC transporters for TCA cycle intermediates. ( C ) Forest plot showing the hazard ratios (HR) for multiple genes encoding SLC transporters of TCA cycle intermediates in HCC. The horizontal line represents the 95% confidence interval. ( D ) Heatmap of detectable SLC transporters for TCA cycle intermediates in heterogeneous primary liver cancer models generated by genome editing of cancer driver genes selected by mutational frequency from human HCC cohorts (PRJNA674008). ( E ) qPCR analysis to screen candidate SLC transporters for HCC progression based on the relative expression of SLC transporters in the HTVi model ( n = 4 for the control group and n = 5 for the model group), mouse HCC Hepa1-6 cells, AML12 cells, and MPHs ( n = 3 independent experiments). ( F ) Venn diagram showing the overlap of significantly differentially expressed SLC transporters in the HTVi model, mouse HCC Hepa1-6 cells, and normal hepatocytes (AML12 and MPHs). ( G and H ) SLC13A2 expression in liver tissues from HTVi, AAV-cMYC/nRAS, and STZ-HFD HCC model. The data are presented as means ± SEM. * P < 0.05; ** P < 0.01, two-tailed unpaired Student’s t test. Ctrl, control; n.d., not determined; NS, not significant.

    Article Snippet: The mouse HCC cell line Hepa1-6 and mouse normal hepatocyte cell line AML12 were obtained from the American Type Culture Collection as described previously ( ).

    Techniques: Metabolomic, Generated, Expressing, Control, Two Tailed Test

    Lactate-induced lipid accumulation in hepatocytes in vitro . Alpha mouse liver 12 (AML12) cells were treated with different doses of sodium L-lactate for 4 days. (A) Cell viability was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (B) Intracellular lipid is stained with Oil Red O. The upper images representative gross morphology of Oil Red O staining of AML12 cells. The below representative pictures of cells were taken by a microscope at 200× original magnification. Scale bar: 100 μm. (C) Quantification of intracellular triglyceride (TG) content. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001.

    Journal: Diabetes & Metabolism Journal

    Article Title: Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation

    doi: 10.4093/dmj.2024.0531

    Figure Lengend Snippet: Lactate-induced lipid accumulation in hepatocytes in vitro . Alpha mouse liver 12 (AML12) cells were treated with different doses of sodium L-lactate for 4 days. (A) Cell viability was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (B) Intracellular lipid is stained with Oil Red O. The upper images representative gross morphology of Oil Red O staining of AML12 cells. The below representative pictures of cells were taken by a microscope at 200× original magnification. Scale bar: 100 μm. (C) Quantification of intracellular triglyceride (TG) content. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001.

    Article Snippet: The alpha mouse liver 12 (AML12) mouse hepatocyte cell line was procured from the American Type Culture Collection (Manassas, VA, USA) and grown in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 supplemented with 1X insulin-transferrin-selenium (ITS) supplement, 40 ng/mL dexamethasone, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 g/L glutamine, and 10% fetal bovine serum at 37°C with 95% air and 5% CO2.

    Techniques: In Vitro, MTT Assay, Staining, Microscopy, Control

    G-protein-coupled receptor 81 (GPR81) may regulate monocarboxylate transporter 1 (MCT1) expression in hepatocytes in vitro . (A) Alpha mouse liver 12 (AML12) cells were treated with sodium L-lactate 20 and 40 mM for different time course. Western blot analysis was performed to assess the expression levels of GPR81, MCT1, and MCT4 in AML12 cells. (B) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 3 days. Western blot analysis was conducted to evaluate the expression levels of GPR81 and MCT1 in AML12 cells. The intensities of the bands in the Western blot images were quantified using Image Lab software and are displayed in the corresponding plot alongside the representative blot images. The protein levels were normalized to β-actin expression. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.001, lactate 20 mM treated group vs. control; d P <0.05, e P <0.01, f P <0.001, lactate 40 mM treated group vs. control; statistical significance compared with si-scramble is indicated by g P <0.05, h P <0.01, i P <0.001, with siGPR81 indicated j P <0.01.

    Journal: Diabetes & Metabolism Journal

    Article Title: Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation

    doi: 10.4093/dmj.2024.0531

    Figure Lengend Snippet: G-protein-coupled receptor 81 (GPR81) may regulate monocarboxylate transporter 1 (MCT1) expression in hepatocytes in vitro . (A) Alpha mouse liver 12 (AML12) cells were treated with sodium L-lactate 20 and 40 mM for different time course. Western blot analysis was performed to assess the expression levels of GPR81, MCT1, and MCT4 in AML12 cells. (B) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 3 days. Western blot analysis was conducted to evaluate the expression levels of GPR81 and MCT1 in AML12 cells. The intensities of the bands in the Western blot images were quantified using Image Lab software and are displayed in the corresponding plot alongside the representative blot images. The protein levels were normalized to β-actin expression. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.001, lactate 20 mM treated group vs. control; d P <0.05, e P <0.01, f P <0.001, lactate 40 mM treated group vs. control; statistical significance compared with si-scramble is indicated by g P <0.05, h P <0.01, i P <0.001, with siGPR81 indicated j P <0.01.

    Article Snippet: The alpha mouse liver 12 (AML12) mouse hepatocyte cell line was procured from the American Type Culture Collection (Manassas, VA, USA) and grown in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 supplemented with 1X insulin-transferrin-selenium (ITS) supplement, 40 ng/mL dexamethasone, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 g/L glutamine, and 10% fetal bovine serum at 37°C with 95% air and 5% CO2.

    Techniques: Expressing, In Vitro, Western Blot, Small Interfering RNA, Software, Control

    G-protein-coupled receptor 81 (GPR81) played a major role in regulating lipid accumulation in lactate-treated alpha mouse liver 12 (AML12) cells. (A) AML12 cells were treated with L-lactate at 20 mM with or without AZD3965 at 100 nM for 4 days. Lipid accumulation was evaluated using Oil Red O staining. (B) AML12 cells were treated with sodium L-lactate 20 and 40 mM for 3 days. The isolation of plasma membrane (PM) and cytosol fractions was performed, and the expression of GPR81 and monocarboxylate transporter 1 (MCT1) in AML12 cells was assessed. Na/K ATPase served as a housekeeping marker for the PM, while tubulin served as a housekeeping marker for the cytosol. (C) Immunofluorescence of MCT1 (red) and nuclei (4ʹ,6-diamidino2-phenylindole [DAPI] blue). Scale bar: 20 μm. (D) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 4 days. The accumulation of lipids in AML12 cells was visualized using Oil Red O staining. Statistical significance compared with control is indicated by a P <0.05, b P <0.01. Statistical significance compared with si-scramble is indicated by c P <0.05, d P <0.001, with siGPR81 indicated e P <0.001.

    Journal: Diabetes & Metabolism Journal

    Article Title: Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation

    doi: 10.4093/dmj.2024.0531

    Figure Lengend Snippet: G-protein-coupled receptor 81 (GPR81) played a major role in regulating lipid accumulation in lactate-treated alpha mouse liver 12 (AML12) cells. (A) AML12 cells were treated with L-lactate at 20 mM with or without AZD3965 at 100 nM for 4 days. Lipid accumulation was evaluated using Oil Red O staining. (B) AML12 cells were treated with sodium L-lactate 20 and 40 mM for 3 days. The isolation of plasma membrane (PM) and cytosol fractions was performed, and the expression of GPR81 and monocarboxylate transporter 1 (MCT1) in AML12 cells was assessed. Na/K ATPase served as a housekeeping marker for the PM, while tubulin served as a housekeeping marker for the cytosol. (C) Immunofluorescence of MCT1 (red) and nuclei (4ʹ,6-diamidino2-phenylindole [DAPI] blue). Scale bar: 20 μm. (D) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 4 days. The accumulation of lipids in AML12 cells was visualized using Oil Red O staining. Statistical significance compared with control is indicated by a P <0.05, b P <0.01. Statistical significance compared with si-scramble is indicated by c P <0.05, d P <0.001, with siGPR81 indicated e P <0.001.

    Article Snippet: The alpha mouse liver 12 (AML12) mouse hepatocyte cell line was procured from the American Type Culture Collection (Manassas, VA, USA) and grown in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 supplemented with 1X insulin-transferrin-selenium (ITS) supplement, 40 ng/mL dexamethasone, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 g/L glutamine, and 10% fetal bovine serum at 37°C with 95% air and 5% CO2.

    Techniques: Staining, Isolation, Clinical Proteomics, Membrane, Expressing, Marker, Immunofluorescence, Small Interfering RNA, Control

    Lactate-induced G-protein-coupled receptor 81 (GPR81) activation promotes hepatocyte lipogenesis and fatty acid storage in vitro . (A) Alpha mouse liver 12 (AML12) cells were treated with sodium L-lactate 20 and 40 mM for 3 days. (B) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 3 days. Cell lysates were then analyzed via Western blot to determine protein levels. Representative images of immunoblots of lipogenesis markers. β-Actin is a loading control. SREBP1c, sterol regulatory element-binding protein 1c; ACC, acetyl-CoA carboxylase; SCD1, stearoyl-CoA desaturase-1; FABP4, fatty acid binding protein 4; PPARα, peroxisome proliferator-activated receptor alpha; CPT1, carnitine palmitoyltransferase I; NS, not significant. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001. Statistical significance compared with si-scramble is indicated by d P <0.05, e P <0.01, with siGPR81 indicated f P <0.05, g P <0.01.

    Journal: Diabetes & Metabolism Journal

    Article Title: Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation

    doi: 10.4093/dmj.2024.0531

    Figure Lengend Snippet: Lactate-induced G-protein-coupled receptor 81 (GPR81) activation promotes hepatocyte lipogenesis and fatty acid storage in vitro . (A) Alpha mouse liver 12 (AML12) cells were treated with sodium L-lactate 20 and 40 mM for 3 days. (B) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 3 days. Cell lysates were then analyzed via Western blot to determine protein levels. Representative images of immunoblots of lipogenesis markers. β-Actin is a loading control. SREBP1c, sterol regulatory element-binding protein 1c; ACC, acetyl-CoA carboxylase; SCD1, stearoyl-CoA desaturase-1; FABP4, fatty acid binding protein 4; PPARα, peroxisome proliferator-activated receptor alpha; CPT1, carnitine palmitoyltransferase I; NS, not significant. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001. Statistical significance compared with si-scramble is indicated by d P <0.05, e P <0.01, with siGPR81 indicated f P <0.05, g P <0.01.

    Article Snippet: The alpha mouse liver 12 (AML12) mouse hepatocyte cell line was procured from the American Type Culture Collection (Manassas, VA, USA) and grown in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 supplemented with 1X insulin-transferrin-selenium (ITS) supplement, 40 ng/mL dexamethasone, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 g/L glutamine, and 10% fetal bovine serum at 37°C with 95% air and 5% CO2.

    Techniques: Activation Assay, In Vitro, Small Interfering RNA, Western Blot, Control, Binding Assay

    Lactate-mediated G-protein-coupled receptor 81 (GPR81) activation regulates 5’ adenosine monophosphate-activated protein kinase (AMPK) in alpha mouse liver 12 (AML12) cells. (A) AML12 cells were treated with sodium L-lactate 20 and 40 mM for 3 days. (B) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 4 days. Cell lysates were analyzed by Western blot to measure the protein levels of phosphorylation AMPK (p-AMPK) and AMPK. (C) AML12 cells were treated with lactate for 2 days and then co-treated with or without 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) 100 µM for next 2 days. Lipid accumulation was evaluated using Oil Red O staining. (D) AML12 cells were treated with lactate for 2 days and then co-treated with or without AICAR 100 µM for next 1 day. Representative images of immunoblots of mature form of sterol regulatory element-binding protein 1c (SREBP1c), CD36, and fatty acid binding protein 4 (FABP4). β-Actin or tubulin is a loading control. NS, not significant. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001. Statistical significance compared with si-scramble is indicated by d P <0.01, with siGPR81 indicated e P <0.01. Statistical significance compared with lactate 20 mM is indicated by f P <0.05, g P <0.01, h P <0.001.

    Journal: Diabetes & Metabolism Journal

    Article Title: Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation

    doi: 10.4093/dmj.2024.0531

    Figure Lengend Snippet: Lactate-mediated G-protein-coupled receptor 81 (GPR81) activation regulates 5’ adenosine monophosphate-activated protein kinase (AMPK) in alpha mouse liver 12 (AML12) cells. (A) AML12 cells were treated with sodium L-lactate 20 and 40 mM for 3 days. (B) AML12 cells were treated with small interfering RNA (siRNA) 50 nM with or without lactate 20 mM for 4 days. Cell lysates were analyzed by Western blot to measure the protein levels of phosphorylation AMPK (p-AMPK) and AMPK. (C) AML12 cells were treated with lactate for 2 days and then co-treated with or without 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) 100 µM for next 2 days. Lipid accumulation was evaluated using Oil Red O staining. (D) AML12 cells were treated with lactate for 2 days and then co-treated with or without AICAR 100 µM for next 1 day. Representative images of immunoblots of mature form of sterol regulatory element-binding protein 1c (SREBP1c), CD36, and fatty acid binding protein 4 (FABP4). β-Actin or tubulin is a loading control. NS, not significant. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.0001. Statistical significance compared with si-scramble is indicated by d P <0.01, with siGPR81 indicated e P <0.01. Statistical significance compared with lactate 20 mM is indicated by f P <0.05, g P <0.01, h P <0.001.

    Article Snippet: The alpha mouse liver 12 (AML12) mouse hepatocyte cell line was procured from the American Type Culture Collection (Manassas, VA, USA) and grown in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 supplemented with 1X insulin-transferrin-selenium (ITS) supplement, 40 ng/mL dexamethasone, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 g/L glutamine, and 10% fetal bovine serum at 37°C with 95% air and 5% CO2.

    Techniques: Activation Assay, Small Interfering RNA, Western Blot, Phospho-proteomics, Staining, Binding Assay, Control

    Lactate- induced glycolysis in alpha mouse liver 12 (AML12) cells and hepatic lipid accumulation zebrafish. (A) Seahorse analysis of extracellular acidification rate (ECAR), (B) non-glycolytic acidification, (C) glycolysis, (D) glycolytic capacity, and (E) glycolytic reserve were assessed in AML12 cells treated with sodium L-lactate 20 and 40 mM for 3 days. (F) To detect the hepatic response to lactate, we utilized selective fluorescent staining (Nile red) for intracellular lipid droplets in transgenic (Tg) (fabp10a: cyan fluorescent protein [CFP]) zebrafish larvae treated with or without lactate 10 mM. Figures are magnified as ×200. Quantitative analysis of the area of lipid droplet in liver based on Nile Red staining. (G) Lactate-induced lipid accumulation mostly in the liver not in muscle or adipose tissue in zebrafish model Nile red staining for intracellular lipid droplets in Tg (fabp10a: CFP) zebrafish larvae treated with or without lactate 10 mM. Scale bar indicated 100 µm. OD, optical density; 2-DG, 2-deoxy-d-glucose; DMSO, dimethyl sulfoxide; DA, dorsal aorta; L, liver; SB, swim bladder; SIA, supra-intestinal artery; VTA, vertebral artery. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.001, d P <0.0001.

    Journal: Diabetes & Metabolism Journal

    Article Title: Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation

    doi: 10.4093/dmj.2024.0531

    Figure Lengend Snippet: Lactate- induced glycolysis in alpha mouse liver 12 (AML12) cells and hepatic lipid accumulation zebrafish. (A) Seahorse analysis of extracellular acidification rate (ECAR), (B) non-glycolytic acidification, (C) glycolysis, (D) glycolytic capacity, and (E) glycolytic reserve were assessed in AML12 cells treated with sodium L-lactate 20 and 40 mM for 3 days. (F) To detect the hepatic response to lactate, we utilized selective fluorescent staining (Nile red) for intracellular lipid droplets in transgenic (Tg) (fabp10a: cyan fluorescent protein [CFP]) zebrafish larvae treated with or without lactate 10 mM. Figures are magnified as ×200. Quantitative analysis of the area of lipid droplet in liver based on Nile Red staining. (G) Lactate-induced lipid accumulation mostly in the liver not in muscle or adipose tissue in zebrafish model Nile red staining for intracellular lipid droplets in Tg (fabp10a: CFP) zebrafish larvae treated with or without lactate 10 mM. Scale bar indicated 100 µm. OD, optical density; 2-DG, 2-deoxy-d-glucose; DMSO, dimethyl sulfoxide; DA, dorsal aorta; L, liver; SB, swim bladder; SIA, supra-intestinal artery; VTA, vertebral artery. Statistical significance compared with control is indicated by a P <0.05, b P <0.01, c P <0.001, d P <0.0001.

    Article Snippet: The alpha mouse liver 12 (AML12) mouse hepatocyte cell line was procured from the American Type Culture Collection (Manassas, VA, USA) and grown in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 supplemented with 1X insulin-transferrin-selenium (ITS) supplement, 40 ng/mL dexamethasone, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 g/L glutamine, and 10% fetal bovine serum at 37°C with 95% air and 5% CO2.

    Techniques: Staining, Transgenic Assay, Control